EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel coumarin-6-sulfonamide-chalcone hybrids as glutathione transferase P1-1 inhibitors

Ahmed Sabt iD, Stefanos Kitsos, Manal S Ebaid, Veronika Furlan, Panagiota D Pantiora, Magdalini Tsolka, Eslam B Elkaeed, Mohamed Farouk Hamissa, Nikolaos Angelis, Ourania E Tsitsilonis, Anastassios C Papageorgiou, Urban Bren und 1 weitere

PLOS ONE · 14.08.2024 · 19 (8) · e0306124

DOI: 10.1371/journal.pone.0306124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 14.08.2024. Verfasst von Ahmed Sabt und 12 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Institute, National Research Center, Dokki, Cairo, Egypt. Hauptthemen laut MEDLINE: Coumarins, Molecular Docking Simulation, Glutathione S-Transferase pi, Sulfonamides. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research at Northern Border University, Arar, KSA, Slovenian Research and Innovation Agency (ARIS) program, Slovenian Ministry of Science and Education project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug resistance (MDR) mechanisms in cancer cells are greatly influenced by glutathione transferase P1-1 (hGSTP1-1). The use of synthetic or natural compounds as hGSTP1-1 inhibitors is considered an effective approach to overcome MDR. Nine compounds consisting of coumarin-6-sulfonamide linked to chalcone derivatives were synthesized and evaluated for their ability to inhibit hGSTP1-1. Among the synthetic derivatives, compounds 5g , 5f , and 5a displayed the most potent inhibitory effect, with IC 50 values of 12.2 ± 0.5 μΜ, 12.7 ± 0.7 and 16.3 ± 0.6, respectively. Kinetic inhibition analysis of the most potent molecule, 5g , showed that it behaves as a mixed-type inhibitor of the target enzyme. An in vitro cytotoxicity assessment of 5a , 5f, and 5g against the human prostate cancer cell lines DU-145 and PC3, as well as the breast cancer cell line MCF-7, demonstrated that compound 5g exhibited the most pronounced cytotoxic effect on all tested cell lines. Molecular docking studies were performed to predict the structural and molecular determinants of 5g , 5f , and 5a binding to hGSTP1-1. In agreement with the experimental data, the results revealed that 5g exhibited the lowest docking score among the three studied inhibitors as a consequence of shape complementarity, governed by van der Waals, hydrogen bonds and a π-π stacking interaction. These findings suggest that coumarin-chalcone hybrids offer new perspectives for the development of safe and efficient natural product-based sensitizers that can target hGSTP1-1 for anticancer purposes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoumarinsMolecular Docking SimulationGlutathione S-Transferase piSulfonamidesHumansCell Line, TumorChalconeAntineoplastic AgentsChalconesEnzyme InhibitorsMCF-7 Cells

Substanzen

CoumarinsGlutathione S-Transferase piSulfonamidesChalconeAntineoplastic AgentsChalconesEnzyme InhibitorsGSTP1 protein, human

Autor:innen und Institutionen

  • Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Institute, National Research Center, Dokki, Cairo, Egypt.
  • Laboratory of Enzyme Technology, Department of Biotechnology, School of Applied Biology and Biotechnology, Agricultural University of Athens, Athens, Greece.
  • Department of Chemistry, College of Science, Northern Border University, Arar, Saudi Arabia.
  • Faculty of Chemistry and Chemical Engineering, University of Maribor, Maribor, Slovenia.
  • Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Diriyah, Saudi Arabia.
  • Institute of Organic Chemistry and Biochemistry, Academy of Sciences, Prague, Czech Republic.

ORCID-Profile: Ahmed Sabt

Förderung

  • Deanship of Scientific Research at Northern Border University, Arar, KSA
  • Slovenian Research and Innovation Agency (ARIS) program
  • Slovenian Ministry of Science and Education project

Zitieren

APA

Sabt, A., Kitsos, S., Ebaid, M. S., Furlan, V., Pantiora, P. D., Tsolka, M., Elkaeed, E. B., Hamissa, M. F., Angelis, N., Tsitsilonis, O. E., Papageorgiou, A. C., Bren, U., & Labrou, N. E. (2024). Novel coumarin-6-sulfonamide-chalcone hybrids as glutathione transferase P1-1 inhibitors. PLOS ONE, 19(8), e0306124. https://doi.org/10.1371/journal.pone.0306124

Vancouver

Sabt A, Kitsos S, Ebaid MS, Furlan V, Pantiora PD, Tsolka M, et al. Novel coumarin-6-sulfonamide-chalcone hybrids as glutathione transferase P1-1 inhibitors. PLOS ONE. 2024;19(8):e0306124. doi:10.1371/journal.pone.0306124

BibTeX
@article{Sabt2024,
  author = {Sabt, Ahmed and Kitsos, Stefanos and Ebaid, Manal S and Furlan, Veronika and Pantiora, Panagiota D and Tsolka, Magdalini and Elkaeed, Eslam B and Hamissa, Mohamed Farouk and Angelis, Nikolaos and Tsitsilonis, Ourania E and Papageorgiou, Anastassios C and Bren, Urban and Labrou, Nikolaos E},
  title = {Novel coumarin-6-sulfonamide-chalcone hybrids as glutathione transferase P1-1 inhibitors},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {8},
  pages = {e0306124},
  doi = {10.1371/journal.pone.0306124}
}
Kostenlos starten →